Walmart to eliminate jobs, close NC office as part of relocation plan: Reports
Walmart is eliminating several jobs and closing its Charlotte, North Carolina office as it relocates employees to its main hubs in California and Arkansas, according to multiple reports citing an internal memo.
The multinational retail corporation is asking staffers based in Hoboken, New Jersey, and other smaller offices, to relocate to its newly opened headquarters in Bentonville, Arkansas and its office in Sunnyvale, California, Donna Morris, Walmart's chief people officer, wrote in a memo viewed by Bloomberg News and Reuters.
'We are making these changes to put key capabilities together, encouraging speed and shared understanding,' Morris wrote in the recent memo, per the outlets.
USA TODAY contacted Walmart on Wednesday but has not received a response.
Why is Walmart relocating?
This decision is a part of Walmart's bigger relocation strategy that began last year, and it's occurring when many U.S. corporations are mandating that employees return to the office three to five days a week.
Need a break? Play the USA TODAY Daily Crossword Puzzle.
With the closure of Walmart's Charlotte office and the cutting of numerous corporate roles as part of this relocation process, hundreds of jobs are expected to be eliminated, Bloomberg reported, citing a person familiar with the matter.
In 2024, Walmart asked employees in Dallas, Atlanta, and Toronto to relocate to bigger hubs, most of which went to the main office in Bentonville. Changes in 'some parts of our business … will result in a reduction of several hundred campus roles,' Morris said in May in a separate memo to employees shared with USA TODAY.
'We believe that being together, in person, makes us better and helps us to collaborate, innovate and move even faster,' Morris said in the 2024 memo. 'We also believe it helps strengthen our culture as well as grow and develop our associates.'

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Tesla's Optimus humanoid robot program head exiting firm, Bloomberg News reports
(Reuters) -The head of Tesla's Optimus program, Milan Kovac, is leaving the company, casting uncertainty over chief executive Elon Musk's humanoid robot project, Bloomberg News reported on Friday, citing a person familiar with the matter. Kovac, vice president and head of engineering for Optimus, told colleagues on Friday that he was departing, effective immediately. Ashok Elluswamy, who leads Tesla's autopilot teams, will take on Kovac's role, the report said. Tesla, Kovac and Elluswamy did not immediately respond to Reuters requests for comment. Musk has earlier said he expected Tesla to make thousands of Optimus robots this year. He said in April that China's export restrictions on rare-earth magnets had affected production of the humanoid robots. Tesla has shifted focus to launching the robots and its robotaxi service, with much of the company's valuation hanging on that bet. "The only things that matter in the long term are autonomy and Optimus," Musk told CNBC in an interview in May.
Yahoo
an hour ago
- Yahoo
US goods import drop by a record 20% in April
US goods imports fell 20% in April, a record drop reported by the US Census Bureau, coming off of President Trump's April 8 "Liberation Day" tariffs. Yahoo Finance senior columnist Rick Newman discusses supply chain shocks and whether Elon Musk can rally opposition to Trump's "Big, Beautiful" tax and spending bill. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here. US goods imports plummeted in April, falling by 20% from the prior month. The numbers giving some startling insights into the challenges everyday shoppers may be facing over the next few months. For more on the looming import shortage, let's welcome in Yahoo Finance's Rick Newman for this week's rendition of Trumpnomics. So, Rick, what do we learn from those numbers? Hey, guys. Uh, you know, most people pay no attention to import data, export data. I do. Uh, and, uh, it's pretty startling when you see the biggest drop month to month in imports on record, in data that goes back to 1992. We know why that is, because, uh, companies do not want to import, uh, stuff from other countries with the Trump tariffs in place. So, a lot of companies that import stuff, there's big companies like Walmart, Walmart, and a bunch of very small businesses. Um, a lot of them are just waiting. They they think maybe Trump will make some of these trade deals, and the current tariff rates will go lower. And if they can get pay a lower tax in the future, uh, they'd rather do that. Others, we know they are actually paying the higher tariffs because, uh, tariff revenue actually went up, even though imports went down in April and May. This is all coming to a store near you sometime soon. I mean, these are not these seem like abstract numbers, but this is telling you that the amount of stuff coming into the United States is declining. Uh, I've been talking to some economists and other analysts who are likening this to the early days of the Covid pandemic in 2020, when there were, uh, huge disruptions in supply chains. I mean, think back to what that was like. We had some product shortages on store shelves. After a while, we saw a lot of big price increases. Now, that is not baked in yet. Um, if Trump relents on, uh, his tariffs, then maybe we it won't be quite that bad. But if things stay like they are, we're going to start to see COVID style shortages and price hikes within one, two, or three months. Rick, switching gears, I have a different question for you, which is, I am curious whether you think the Trump Musk bromance breakup could impact Trump's budget bill. And here I have a note from Brian Gardner, very smart strategist over at Stifel. Here was his take, Rick. Here's what he told his clients, speaking of the bromance breakup. Brian says, unlikely to result in meaningful changes to the One Big Beautiful Bill. He says that does not mean that some Senate Republicans won't try to reduce spending by more than what the House proposed, but Musk's sway among Republican voters, he says, is limited. It's unlikely that he'll be able to influence a legislative process that has already moved well down the tracks. You agree with Brian, Rick? Disagree? What do you say? Man, I was wondering what your out of left field question was going to be, and I'm like, Musk, Musk, Musk, it's got to be Musk, I guess, right. Um, I think it depends what happens next. I think it depends how hard Elon Musk wants to go after this bill. And you have to keep in mind that, um, Musk does not need to persuade five or 10 or 20% of Republican voters that this bill stinks. I mean, most most Americans are not paying attention to this bill. They'll they'll, you know, figure out what's in it after it passes. What who Musk is talking to is a small number of conservatives in the House and Senate, um, who who don't like the bill. They do not almost none of them want to be the lone Republican who goes up against Trump and bucks his legislation, uh, and might bring down the whole bill. But if Musk gives them top cover, maybe something will happen. So, I think, you know, having tweeted about this bill a few times in the last week, that's not enough. If he really wants to go to the mat and kill this thing, um, he's going to have to keep at it. He's going to have to start talking to people in Congress, um, and and and see what kind of, uh, muscle twisting he can really do. Um, now we do we know where this is headed? I think we have no idea. He is completely unpredictable. Um, he's created a firestorm here. Is he just going to retreat? I think he's going to continue to agitate. I just don't know if it's going to be enough to make a difference. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Revelation-Backed Omada Health Jumps After $150 Million IPO
(Bloomberg) -- Omada Health Inc. shares ended their debut trading day exactly where they started after the digital health-care company raised $150 million in its initial public offering. Next Stop: Rancho Cucamonga! ICE Moves to DNA-Test Families Targeted for Deportation with New Contract Where Public Transit Systems Are Bouncing Back Around the World US Housing Agency Vulnerable to Fraud After DOGE Cuts, Documents Warn Trump Said He Fired the National Portrait Gallery Director. She's Still There. The stock climbed 21% to close at $23 on Friday in New York — the same price it opened at — higher than its IPO price of $19 per share. The stock had jumped as much as 49% during the the trading session. The San Francisco-based company sold 7.9 million shares at $19 each after offering them at $18 to $20 apiece, according to its filings with the US Securities and Exchange Commission. The trading gives Omada a market value of $1.3 billion based on the number of outstanding shares listed in its filings. The IPO adds to the growing pace of US first-time share sales this year, which have raised around $24.9 billion so far, versus $17.6 billion in the same period last year, according to data compiled by Bloomberg. Shares of health-care upstarts that went public on US exchanges this year are also up by a weighted average of roughly 18%, according to Bloomberg calculations. An IPO last month for digital physical therapy provider Hinge Health Inc. — a competitor to Omada — raised $503 million, and shares have risen about 19% since its debut. Omada's offering closed with orders for more than 15 times the shares available, with allocations going to a highly concentrated group of investors, Bloomberg News has reported. Virtual Care Founded in 2011, Omada provides virtual care in between doctor's visits to help people manage chronic conditions including diabetes and prediabetes, obesity, hypertension and musculoskeletal conditions, according to the filing. Users track metrics including weight, blood pressure and blood glucose values to the company's platform, which includes a mobile app. Unlike other digital health firms, Omada doesn't offer GLP-1 weight loss drugs, the filing shows. Instead it has programs to support people using them, including coaching and nutrition guidance, to manage muscle loss and stop the weight from returning when they cease taking the medication, according to the filing. About 50,000 of Omada's 679,000 members are on GLP-1s, co-founder and Chief Executive Officer Sean Duffy said in an interview with Bloomberg News. It's a relatively new business for the company that has expanded in the past year as part of its partnership with Cigna Group's Express Scripts unit, he said. 'For support, especially in chronic disease, it's very helpful that someone feels they are not just doing this for themselves but for someone else - to have someone rooting for you in your corner is really important for outcomes,' Duffy said. Omada is using AI to automate the virtual care it provides to chronic disease sufferers, though the services are 'human-led,' he said. 'Our members tell us they want a person and I am yet to see anyone that feels accountable to ChatGPT,' Duffy said. Omada has over 2,000 customers including employers and health systems, and more than 679,000 total members enrolled in one or more programs, according to the filing. Largest Shareholder Revelation Partners is Omada's largest shareholder, beneficially owning 10.9% of the company before the offering, according to the filing. USVP has 9.9% of the shares, Andreessen Horowitz has 9.6% and FMR has 9.3%, the filing shows. Omada was valued at more than $1 billion in a 2022 funding round led by Fidelity Management & Research Co., it said in a statement at the time. The company had a net loss of $9.4 million on revenue of close to $55 million in the first three months of 2025, compared with a net loss of nearly $19 million on revenue of $35.1 million in the same period a year earlier, the filing shows. The offering was led by Morgan Stanley, Goldman Sachs Group Inc. and JPMorgan Chase & Co., the filing shows. The company's shares trade on the Nasdaq Global Market under the symbol OMDA. (Updates with closing prices.) Cavs Owner Dan Gilbert Wants to Donate His Billions—and Walk Again The SEC Pinned Its Hack on a Few Hapless Day Traders. The Full Story Is Far More Troubling YouTube Is Swallowing TV Whole, and It's Coming for the Sitcom Is Elon Musk's Political Capital Spent? Trump Considers Deporting Migrants to Rwanda After the UK Decides Not To ©2025 Bloomberg L.P.